Circulating endocannabinoids in insulin sensitive vs. Insulin resistant obese postmenopausal women. A MONET group study-Reference-Cited by-同舟云学术

Circulating endocannabinoids in insulin sensitive vs. Insulin resistant obese postmenopausal women. A MONET group study

Published:2013-10-19 Issue:1 Volume:22 Page:211-216
ISSN:1930-7381
Container-title:Obesity
language:en
Short-container-title:Obesity

Author:

Abdulnour Joseph¹²,Yasari Siham¹²,Rabasa‐Lhoret Rémi³⁴,Faraj May.³⁴,Petrosino Stefania⁵,Piscitelli Fabiana⁵,Prud' homme Denis¹²,Marzo Vincenzo⁵

Affiliation:

1. School of Human Kinetics Faculty of Health ScienceUniversity of OttawaOttawa ON Canada

2. Behavioural and Metabolic Research UnitUniversity of OttawaOttawa Ontario Canada

3. PROMD Platfrom for research in Obesity Metabolism and DiabetesMontreal institute for clinical research (IRCM)Montreal Quebec Canada

4. Nutrition department faculty of medecineUniversité de MontréalMontréal Quebec Canada

5. Endocannabinoid Research Group Institute of Biomolecular ChemistryConsiglio Nazionale delle RicercheVia Campi Flegrei 34, Comprensorio OlivettiPozzuoli NA80078 Italy

Publisher

Wiley

Subject

Nutrition and Dietetics,Endocrinology,Endocrinology, Diabetes and Metabolism,Medicine (miscellaneous)

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/oby.20498

Reference31 articles.

1. The Continuing Epidemics of Obesity and Diabetes in the United States

2. Body Mass Index, Metabolic Syndrome, and Risk of Type 2 Diabetes or Cardiovascular Disease

3. Metabolically Healthy Obesity and Risk of All-Cause and Cardiovascular Disease Mortality

4. Characterizing the profile of obese patients who are metabolically healthy

5. Circulating endocannabinoid levels, abdominal adiposity and related cardiometabolic risk factors in obese men

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The circulating and central endocannabinoid system in obesity and weight loss;International Journal of Obesity;2024-06-04

2. Endocannabinoids and cortisol in plasma, aqueous and tear samples of primary angle closure glaucoma versus controls;European Journal of Ophthalmology;2024-04-13

3. Endocannabinoid system alterations in schizophrenia: association with cannabis use and antipsychotic medication;European Archives of Psychiatry and Clinical Neuroscience;2024-03-19

4. Investigating the alterations of endocannabinoidome signaling in the human small intestine in the context of obesity and type 2 diabetes;Heliyon;2024-03

5. Hepatic targeting of the centrally active cannabinoid 1 receptor (CB1R) blocker rimonabant via PLGA nanoparticles for treating fatty liver disease and diabetes;Journal of Controlled Release;2023-01